| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.3 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |